{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T20:51:59Z","timestamp":1771707119914,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0156115","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T18:33:50Z","timestamp":1464028430000},"page":"e0156115","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations"],"prefix":"10.1371","volume":"11","author":[{"given":"Alenka","family":"Gugger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond L.","family":"Barnhill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhardt","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Dehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Moch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Lugassy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewerton","family":"Marques-Maggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth J.","family":"Rushing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mihic-Probst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1474-4422(05)70072-7","article-title":"Therapeutic management of brain metastasis","volume":"4","author":"EC Kaal","year":"2005","journal-title":"Lancet Neurol"},{"issue":"11","key":"ref2","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1097-0142(19840601)53:11<2550::AID-CNCR2820531129>3.0.CO;2-B","article-title":"Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience","volume":"53","author":"S Madajewicz","year":"1984","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/1097-0142(196306)16:6<781::AID-CNCR2820160614>3.0.CO;2-M","article-title":"Metastatic carcinoma in the central nervous system and dorsal root ganglia. A prospective autopsy study","volume":"16","author":"JL Chason","year":"1963","journal-title":"Cancer"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2003.12.016","article-title":"The blood-brain barrier: an overview: structure, regulation, and clinical implications","volume":"16","author":"P Ballabh","year":"2004","journal-title":"Neurobiol Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/ncomms7716","article-title":"Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier","volume":"6","author":"N Tominaga","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/00313020412331282708","article-title":"Angiotropic malignant melanoma and extravascular migratory metastasis: description of 36 cases with emphasis on a new mechanism of tumour spread","volume":"36","author":"RL Barnhill","year":"2004","journal-title":"Pathology"},{"issue":"36","key":"ref7","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final Version of 2009 AJCC Melanoma Staging and Classification","volume":"27","author":"CM Balch","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/1097-0142(19800401)45:7<1604::AID-CNCR2820450715>3.0.CO;2-O","article-title":"Histologic features of tumors and the female superiority in survival from malignant melanoma","volume":"45","author":"HM Shaw","year":"1980","journal-title":"Cancer"},{"issue":"24","key":"ref9","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jnci\/81.24.1893","article-title":"Model predicting survival in stage I melanoma based on tumor progression","volume":"81","author":"WH Clark Jr","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/jid.2010.354","article-title":"Gender differences in melanoma survival: female patients have a decreased risk of metastasis","volume":"131","author":"A Joosse","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"5","key":"ref11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/01.sla.0000216771.81362.6b","article-title":"Gender-Related Differences in Outcome for Melanoma Patients","volume":"243","author":"CR Scoggins","year":"2006","journal-title":"Annals of Surgery"},{"issue":"18","key":"ref12","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1200\/JCO.2011.38.0584","article-title":"Superior outcome of women with stage I\/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials","volume":"30","author":"A Joosse","year":"2012","journal-title":"J Clin Oncol"},{"issue":"18","key":"ref13","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1200\/JCO.2012.44.5031","article-title":"Sex is an independent prognostic indicator for survival and relapse\/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials","volume":"31","author":"A Joosse","year":"2013","journal-title":"J Clin Oncol"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1002\/cncr.23359","article-title":"Age and gender are significant independent predictors of survival in primary cutaneous melanoma","volume":"112","author":"K Lasithiotakis","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1245\/s10434-014-4166-8","article-title":"Sex differences in melanoma survival are not related to mitotic rate of the primary tumor","volume":"22","author":"A Joosse","year":"2015","journal-title":"Annals of surgical oncology"},{"issue":"8","key":"ref16","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1426::AID-CNCR9>3.0.CO;2-C","article-title":"Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model","volume":"80","author":"S Sahin","year":"1997","journal-title":"Cancer"},{"issue":"4","key":"ref17","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.sla.0000090446.63327.40","article-title":"Thin melanomas: predictive lethal characteristics from a 30-year clinical experience","volume":"238","author":"MF Kalady","year":"2003","journal-title":"Annals of surgery"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1002\/cncr.11624","article-title":"Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit","volume":"98","author":"JG McKinnon","year":"2003","journal-title":"Cancer"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archsurg.1992.01420110045011","article-title":"Relationship between disease-free interval and survival in patients with recurrent melanoma","volume":"127","author":"NJ Crowley","year":"1992","journal-title":"Arch Surg"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.critrevonc.2010.04.007","article-title":"Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature","volume":"78","author":"K Kamposioras","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"33","key":"ref21","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1200\/JCO.2012.47.3728","article-title":"Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry","volume":"31","author":"AC Geller","year":"2013","journal-title":"J Clin Oncol"},{"issue":"17","key":"ref22","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1056\/NEJMra022137","article-title":"Skin Cancers after Organ Transplantation","volume":"348","author":"S Euvrard","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","article-title":"Cancer immunoediting from immune surveillance to immune escape","volume":"121","author":"R Kim","year":"2007","journal-title":"Immunology"},{"issue":"7","key":"ref24","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5","article-title":"Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma","volume":"77","author":"CG Clemente","year":"1996","journal-title":"Cancer"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1200\/JCO.2006.08.9755","article-title":"Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma","volume":"25","author":"RC Taylor","year":"2007","journal-title":"J Clin Oncol"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2559.1983.tb02279.x","article-title":"Prognosis in patients with thin malignant melanoma: influence of regression","volume":"7","author":"VJ McGovern","year":"1983","journal-title":"Histopathology"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2559.1989.tb03076.x","article-title":"Thin regressing malignant melanoma: significance of concurrent regional lymph node metastases","volume":"15","author":"HM Shaw","year":"1989","journal-title":"Histopathology"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/path.1093","article-title":"Identification of histological features associated with metastatic potential in thin (&lt;1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group","volume":"197","author":"MG Cook","year":"2002","journal-title":"J Pathol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/1097-0142(197811)42:5<2282::AID-CNCR2820420528>3.0.CO;2-V","article-title":"The regressing thin malignant melanoma: a distinctive lesion with metastatic potential","volume":"42","author":"MA Gromet","year":"1978","journal-title":"Cancer"},{"issue":"5","key":"ref30","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/archderm.138.5.603","article-title":"Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases","volume":"138","author":"J Guitart","year":"2002","journal-title":"Arch Dermatol"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000658-198808000-00004","article-title":"Lethal &quot;thin&quot; malignant melanoma. Identifying patients at risk","volume":"208","author":"CL Slingluff Jr","year":"1988","journal-title":"Annals of surgery"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1245\/s10434-007-9675-2","article-title":"Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy","volume":"15","author":"KT Morris","year":"2008","journal-title":"Annals of surgical oncology"},{"issue":"12","key":"ref33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamadermatol.2015.2235","article-title":"Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis","volume":"151","author":"S Ribero","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/bjd.12586","article-title":"Favourable prognostic role of regression of primary melanoma in AJCC stage I-II patients","volume":"169","author":"S Ribero","year":"2013","journal-title":"The British journal of dermatology"},{"issue":"13","key":"ref35","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1245\/s10434-011-1826-9","article-title":"Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database","volume":"18","author":"RL White Jr","year":"2011","journal-title":"Annals of surgical oncology"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0560.1993.tb00228.x","article-title":"Histologic regression in malignant melanoma: an interobserver concordance study","volume":"20","author":"S Kang","year":"1993","journal-title":"J Cutan Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1476-4598-13-45","article-title":"MEK targeting in N-RAS mutated metastatic melanoma","volume":"13","author":"J Thumar","year":"2014","journal-title":"Mol Cancer"},{"issue":"16","key":"ref38","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"JA Jakob","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.0493","article-title":"Association between NRAS and BRAF mutational status and melanoma-specific survival among patients with higher-risk primary melanoma","volume":"1","author":"NE Thomas","year":"2015","journal-title":"JAMA Oncology"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/bjd.12504","article-title":"The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort","volume":"169","author":"H Ekedahl","year":"2013","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"ref41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/01.cmr.0000232300.22032.86","article-title":"NRAS and BRAF mutations in melanoma tumours in relation to clinical characteristics: a study based on mutation screening by pyrosequencing","volume":"16","author":"E Edlundh-Rose","year":"2006","journal-title":"Melanoma Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0156115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T01:33:57Z","timestamp":1656552837000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0156115"}},"subtitle":[],"editor":[{"given":"Soheil S.","family":"Dadras","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2016,5,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0156115","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}